NASDAQ:KIDS OrthoPediatrics - KIDS Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OrthoPediatrics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. $44.29 +0.56 (+1.28%) (As of 03/31/2023 12:00 AM ET) Add Compare Share Share Today's Range$42.26▼$45.0750-Day Range$39.69▼$49.7752-Week Range$35.67▼$60.75Volume163,089 shsAverage Volume124,316 shsMarket Capitalization$1.02 billionP/E Ratio1,476.83Dividend YieldN/APrice Target$55.17 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability OrthoPediatrics MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside24.6% Upside$55.17 Price TargetShort InterestBearish7.57% of Float Sold ShortDividend StrengthN/ASustainability-1.20Upright™ Environmental ScoreNews Sentiment0.31Based on 2 Articles This WeekInsider TradingSelling Shares$1.12 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.95) to ($0.80) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.96 out of 5 starsMedical Sector551st out of 996 stocksSurgical & Medical Instruments Industry57th out of 104 stocks 2.5 Analyst's Opinion Consensus RatingOrthoPediatrics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $55.17, OrthoPediatrics has a forecasted upside of 24.6% from its current price of $44.29.Amount of Analyst CoverageOrthoPediatrics has only been the subject of 3 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted7.57% of the float of OrthoPediatrics has been sold short.Short Interest Ratio / Days to CoverOrthoPediatrics has a short interest ratio ("days to cover") of 9.1.Change versus previous monthShort interest in OrthoPediatrics has recently increased by 4.50%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldOrthoPediatrics does not currently pay a dividend.Dividend GrowthOrthoPediatrics does not have a long track record of dividend growth. Previous Next 3.9 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreOrthoPediatrics has received a 52.35% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Synthetic bone grafts", "Cervical implants", and "Medical screws" products. See details.Environmental SustainabilityThe Environmental Impact score for OrthoPediatrics is -1.20. Previous Next 1.8 News and Social Media Coverage News SentimentOrthoPediatrics has a news sentiment score of 0.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for OrthoPediatrics this week, compared to 2 articles on an average week.MarketBeat Follows4 people have added OrthoPediatrics to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, OrthoPediatrics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,120,988.00 in company stock.Percentage Held by Insiders29.50% of the stock of OrthoPediatrics is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions97.02% of the stock of OrthoPediatrics is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for OrthoPediatrics are expected to grow in the coming year, from ($0.95) to ($0.80) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of OrthoPediatrics is 1,476.83, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 131.08.Price to Earnings Ratio vs. SectorThe P/E ratio of OrthoPediatrics is 1,476.83, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 128.08.Price to Book Value per Share RatioOrthoPediatrics has a P/B Ratio of 2.68. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About OrthoPediatrics (NASDAQ:KIDS) StockOrthoPediatrics Corp. is an orthopedic company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. It offers products relating to trauma and deformity, scoliosis, and sports medicine and other procedures. The company was founded by Erin Springer Yount and Nick A. Deeter in August 2006 and is headquartered in Warsaw, IN.Read More Receive KIDS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OrthoPediatrics and its competitors with MarketBeat's FREE daily newsletter. Email Address KIDS Stock News HeadlinesMarch 31, 2023 | finance.yahoo.comOrthoPediatrics Corp. Leading Sponsorship at Annual EPOS MeetingMarch 29, 2023 | americanbankingnews.comAnalysts Set OrthoPediatrics Corp. (NASDAQ:KIDS) PT at $55.17April 2, 2023 | Legacy Research (Affiliate) (Ad)Bear market expert makes new predictionNobody believed Larry Benedict's prediction in February 2020. The DOW plunged 3.5%, and he told CNBC, "It seems like there's much more to come." Within a month, the market plummeted 34%. Then, nobody believed Larry at the start of last year, either. He predicted that "all the indexes will be negative for the year," with the Nasdaq leading the way. Once again, he was spot-on.March 6, 2023 | finance.yahoo.comOrthoPediatrics Corp. Named One of the 2023 Best Places to Work in IndianaMarch 4, 2023 | msn.comOrthoPediatrics GAAP EPS of -$0.35 misses by $0.09, revenue of $30.99M misses by $1.13MMarch 3, 2023 | finance.yahoo.comOrthoPediatrics Corp. (NASDAQ:KIDS) Q4 2022 Earnings Call TranscriptMarch 2, 2023 | finance.yahoo.comOrthoPediatrics Full Year 2022 Earnings: Misses ExpectationsFebruary 26, 2023 | finance.yahoo.comOrthoPediatrics Corp. (KIDS) Stock Historical Prices & Data - Yahoo FinanceApril 2, 2023 | Legacy Research (Affiliate) (Ad)Bear market expert makes new predictionNobody believed Larry Benedict's prediction in February 2020. The DOW plunged 3.5%, and he told CNBC, "It seems like there's much more to come." Within a month, the market plummeted 34%. Then, nobody believed Larry at the start of last year, either. He predicted that "all the indexes will be negative for the year," with the Nasdaq leading the way. Once again, he was spot-on.February 14, 2023 | finance.yahoo.comOrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2022 Financial Results on March 1, 2023February 1, 2023 | finance.yahoo.comOrthoPediatrics Corp. Publishes Environmental, Social, and Governance (“ESG”) Summary ReportJanuary 10, 2023 | finance.yahoo.comRespiratory Infections Led OrthoPediatrics Miss Quarterly Sales Expectations, Analyst Calls It Transitory IssueJanuary 9, 2023 | finance.yahoo.comOrthoPediatrics Corp. Announces Preliminary Unaudited Net Revenue for the Fourth Quarter & Full Year 2022, Provides Financial Outlook for 2023January 6, 2023 | finance.yahoo.comOrthoPediatrics Corp. Establishes Direct Sales Organization in GermanyDecember 5, 2022 | finance.yahoo.comOrthoPediatrics Corp. to Host Educational and Networking Events at 18th Annual International Pediatric Orthopaedic Symposium (IPOS)November 4, 2022 | finance.yahoo.comOrthoPediatrics to Participate in Upcoming November ConferencesOctober 28, 2022 | finance.yahoo.comThose who invested in OrthoPediatrics (NASDAQ:KIDS) five years ago are up 122%October 20, 2022 | finance.yahoo.comOrthoPediatrics Corp. Announces Appointment of Jimmy D. McDonald to Board of Directors - Yahoo FinanceOctober 20, 2022 | finance.yahoo.comOrthoPediatrics Corp. Announces Appointment of Jimmy D. McDonald to Board of DirectorsOctober 18, 2022 | globenewswire.comOrthoPediatrics Corp. to Report Third Quarter 2022 Financial Results on November 1, 2022 - GlobeNewswireOctober 18, 2022 | finance.yahoo.comOrthoPediatrics Corp. to Report Third Quarter 2022 Financial Results on November 1, 2022October 7, 2022 | finance.yahoo.comIs it Still Worthy to Own Amazon (AMZN) Shares? - Yahoo FinanceOctober 5, 2022 | nasdaq.comWall Street Analysts See a 32% Upside in OrthoPediatrics (KIDS): Can the Stock Really Move This High? - NasdaqOctober 5, 2022 | finance.yahoo.comWall Street Analysts See a 32% Upside in OrthoPediatrics (KIDS): Can the Stock Really Move This High?October 3, 2022 | nasdaq.comOrthoPediatrics Corp. (NASDAQ:KIDS) insiders sold US$1.5m worth of stock suggesting impending weakness.September 29, 2022 | nasdaq.comStrength Seen in Silk Road Medical (SILK): Can Its 9.3% Jump Turn into More Strength? - NasdaqSeptember 19, 2022 | finance.yahoo.com[Latest Report] Global Orthopedic Prosthetic Devices Market Size Worth 3.97 Billion by 2030 at a 9.5 CAGR: Custom Market Insights (Orthopedic Prosthetic Devices Market Share, Report, Trends, Forecast, Trends, Segmentation) - Yahoo FinanceSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive KIDS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OrthoPediatrics and its competitors with MarketBeat's FREE daily newsletter. Email Address KIDS Company Calendar Last Earnings2/28/2023Today4/01/2023Next Earnings (Estimated)5/03/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:KIDS CUSIPN/A CIK1425450 Webwww.orthopediatrics.com Phone(574) 268-6379Fax574-269-3692Employees133Year FoundedN/APrice Target and Rating Average Stock Price Forecast$55.17 High Stock Price Forecast$62.00 Low Stock Price Forecast$50.00 Forecasted Upside/Downside+24.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)$0.03 Trailing P/E Ratio1,476.83 Forward P/E RatioN/A P/E GrowthN/ANet Income$1.26 million Net Margins1.03% Pretax Margin-3.02% Return on Equity-5.76% Return on Assets-4.66% Debt Debt-to-Equity RatioN/A Current Ratio7.34 Quick Ratio4.81 Sales & Book Value Annual Sales$122.29 million Price / Sales8.33 Cash FlowN/A Price / Cash FlowN/A Book Value$16.54 per share Price / Book2.68Miscellaneous Outstanding Shares22,990,000Free Float16,210,000Market Cap$1.02 billion OptionableNot Optionable Beta0.91 Key ExecutivesDavid R. BaileyPresident, Chief Executive Officer & DirectorFred L. HiteDirector, Chief Operating & Financial OfficerPeter F. ArmstrongChief Medical OfficerJoel BattsSenior Vice President-Science & TechnologyJoseph W. HauserSenior Vice President & General ManagerKey CompetitorsAtrionNASDAQ:ATRILongview Acquisition Corp. IINYSE:LGVCardiovascular SystemsNASDAQ:CSIILeMaitre VascularNASDAQ:LMATNevroNYSE:NVROView All CompetitorsInsiders & InstitutionsMark C ThrodahlSold 4,515 sharesTotal: $197,892.45 ($43.83/share)David R BaileySold 4,052 sharesTotal: $179,908.80 ($44.40/share)Fred HiteSold 4,099 sharesTotal: $179,413.23 ($43.77/share)Gregory A OdleSold 3,421 sharesTotal: $150,626.63 ($44.03/share)Daniel J GerritzenSold 3,315 sharesTotal: $147,915.30 ($44.62/share)View All Insider TransactionsView All Institutional Transactions KIDS Stock - Frequently Asked Questions Should I buy or sell OrthoPediatrics stock right now? 5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for OrthoPediatrics in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" KIDS shares. View KIDS analyst ratings or view top-rated stocks. What is OrthoPediatrics' stock price forecast for 2023? 5 brokers have issued 12 month price objectives for OrthoPediatrics' shares. Their KIDS share price forecasts range from $50.00 to $62.00. On average, they predict the company's stock price to reach $55.17 in the next year. This suggests a possible upside of 24.6% from the stock's current price. View analysts price targets for KIDS or view top-rated stocks among Wall Street analysts. How have KIDS shares performed in 2023? OrthoPediatrics' stock was trading at $39.73 at the beginning of the year. Since then, KIDS shares have increased by 11.5% and is now trading at $44.29. View the best growth stocks for 2023 here. When is OrthoPediatrics' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 3rd 2023. View our KIDS earnings forecast. How were OrthoPediatrics' earnings last quarter? OrthoPediatrics Corp. (NASDAQ:KIDS) released its quarterly earnings results on Tuesday, February, 28th. The company reported ($0.32) EPS for the quarter, missing the consensus estimate of ($0.22) by $0.10. The company earned $30.99 million during the quarter, compared to analysts' expectations of $31.01 million. OrthoPediatrics had a negative trailing twelve-month return on equity of 5.76% and a net margin of 1.03%. What ETFs hold OrthoPediatrics' stock? ETFs with the largest weight of OrthoPediatrics (NASDAQ:KIDS) stock in their portfolio include SPDR S&P Health Care Equipment ETF (XHE), First Trust NASDAQ BuyWrite Income ETF (FTQI), Principal Healthcare Innovators ETF (BTEC) and iShares Micro-Cap ETF (IWC) and What guidance has OrthoPediatrics issued on next quarter's earnings? OrthoPediatrics updated its FY 2023 earnings guidance on Tuesday, February, 28th. The company provided EPS guidance of for the period. The company issued revenue guidance of $146.00 million-$149.00 million, compared to the consensus revenue estimate of $149.57 million. What is Mark Throdahl's approval rating as OrthoPediatrics' CEO? 15 employees have rated OrthoPediatrics Chief Executive Officer Mark Throdahl on Glassdoor.com. Mark Throdahl has an approval rating of 100% among the company's employees. This puts Mark Throdahl in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of OrthoPediatrics own? Based on aggregate information from My MarketBeat watchlists, some companies that other OrthoPediatrics investors own include AbbVie (ABBV), Freeport-McMoRan (FCX), Gilead Sciences (GILD), Intel (INTC), Advanced Micro Devices (AMD), CRISPR Therapeutics (CRSP), Cisco Systems (CSCO), Walt Disney (DIS), Enterprise Products Partners (EPD) and NVIDIA (NVDA). When did OrthoPediatrics IPO? (KIDS) raised $52 million in an initial public offering on Thursday, October 12th 2017. The company issued 4,000,000 shares at $12.00-$14.00 per share. Piper and Jaffray Stifel served as the underwriters for the IPO and William Blair and BTIG were co-managers. What is OrthoPediatrics' stock symbol? OrthoPediatrics trades on the NASDAQ under the ticker symbol "KIDS." How do I buy shares of OrthoPediatrics? Shares of KIDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is OrthoPediatrics' stock price today? One share of KIDS stock can currently be purchased for approximately $44.29. How much money does OrthoPediatrics make? OrthoPediatrics (NASDAQ:KIDS) has a market capitalization of $1.02 billion and generates $122.29 million in revenue each year. The company earns $1.26 million in net income (profit) each year or $0.03 on an earnings per share basis. How many employees does OrthoPediatrics have? The company employs 133 workers across the globe. How can I contact OrthoPediatrics? OrthoPediatrics' mailing address is 2850 Frontier Drive, Warsaw IN, 46582. The official website for the company is www.orthopediatrics.com. The company can be reached via phone at (574) 268-6379, via email at tbui@theruthgroup.com, or via fax at 574-269-3692. This page (NASDAQ:KIDS) was last updated on 4/2/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.